FILTER
Refine your search with the following facets to narrow down your results.
- orphan drugs 8
- stroke 8
- vaccines 8
- cancer 7
- myocardial infarction 7
- pharmacovigilance 7
- Novartis 6
- hypertension 6
- gene therapy 5
- high blood pressure 5
- medicine 5
- cardiovascular diseases 4
- inhibitors 4
- rare diseases 4
- reductions 4
- Genzyme 3
- Marketing Authorization Application 3
- SYGNIS Pharma 3
- UCB 3
- amyotrophic lateral sclerosis 3
- antibodies 3
- bone marrow 3
- breast cancer 3
- chemotherapy 3
- diseases 3
- inflammation 3
- lung diseases 3
- melanoma 3
- milestone payments 3
- multiple sclerosis 3
- pain 3
- pancreatic cancer 3
- tumors 3
- venous thromboembolism 3
- Biofrontera 2
- Brexit 2
- Carrier 2
- Covid-19 2
- Duchenne muscular dystrophy 2
- Friedreich's ataxia 2
- GSK 2
- Genmab 2
- GlaxoSmithKline 2
- Iceland 2
- Life Sciences 2
- Merck Serono 2
- Norway 2
- Pfizer 2
- Sanofi-aventis 2
- Santhera Pharmaceuticals 2
- Spain 2
- T cells 2
- ThromboGenics 2
- Translarna 2
- actinic keratosis 2
- angina 2
- antibiotics 2
- avelumab 2
- blood cancer 2
- cell therapies 2
- cholesterol 2
- coronaviruses 2
- diabetes 2
- drug development 2
- erythropoietic protoporphyria 2
- heart failures 2
- hemophilia A 2
- hepatitis C 2
- hereditary angioedema 2
- immune cells 2
- infectious diseases 2
- interferon 2
- levonorgestrel 2
- liver 2
- merkel cell carcinoma 2
- multiple myeloma 2
- non-Hodgkin lymphoma 2
- osteoarthritis 2
- pandemic influenza 2
- plasticity 2
- prostate cancer 2
- protease inhibitors 2
- regeneration 2
- solution 2
- spinal cord injuries 2
- tissue engineering 2
- vaccine development 2
- validation 2
- veterinary medicine 2
- AA amyloidosis 1
- AGES 1
- AIDS 1
- Abbott 1
- Actelion 1
- Alzheimer's disease 1
- European Medicines Agency (EMA) 122
- Merck KGaA 7
- Novartis International AG 5
- Andrew Lloyd & Associates 3
- Biofrontera AG 3
- Citigate Dewe Rogerson 3
- EuropaBio 3
- Expedeon AG 3
- Genzyme Corporation 3
- GlaxoSmithKline plc (GSK) 3
- Janssen-Cilag N.V. 3
- Pfizer Inc. 3
- U. S. Food and Drug Administration (FDA) 3
- Amsterdam Molecular Therapeutics (AMT) B.V. 2
- Genmab A/S 2
- Kiadis Pharma BV 2
- Merck Serono International S.A. 2
- Oxurion nv 2
- Provepharm SAS 2
- Santhera Pharmaceuticals AG 2
- UCB S.A. 2
- sanofi-aventis Groupe 2
- Æterna Zentaris Inc. 2
- Actelion Pharmaceuticals Ltd 1
- Active Biotech AB 1
- AiCuris GmbH & Co. KG 1
- Ark Therapeutics Group plc 1
- Basilea Pharmaceutica AG 1
- BioMarin Pharmaceutical Inc. 1
- Biogen Inc. 1
- Bionovo, Inc. 1
- CV Therapeutics, Inc. (CVT) 1
- Clavis Pharma ASA 1
- Clinuvel Pharmaceuticals Limited 1
- CureVac AG 1
- Cyclacel Pharmaceuticals, Inc 1
- EUnetHTA 1
- Eisai Co., Ltd 1
- Eisai Europe Ltd. 1
- European Centre for Disease Prevention and Control (ECDC) 1
- European Food Safety Authority (EFSA) 1
- F. Hoffmann-La Roche AG 1
- FORMAC Pharmaceuticals N.V. 1
- FlandersBio 1
- GPC Biotech AG 1
- GVK Biosciences Private Limited 1
- Gendux Molecular Limited 1
- Genentech, Inc. 1
- Genta Inc. 1
- Hybrigenics 1
- Intercell AG 1
- Invitrogen Corporation 1
- Jerini AG 1
- Johnson & Johnson 1
- Keryx Biopharmaceuticals, Inc. 1
- MediGene AG 1
- Merck Sharp & Dohme Limited 1
- Neurochem Inc. 1
- NicOx S.A. 1
- Packer Forbes 1
- Pharming Group N.V. 1
- Stage cell therapeutics GmbH 1
- Swedish Orphan Biovitrum 1
- Takeda Pharmaceutical Company Limited 1
- TiGenix NV 1
- Tibotec Pharmaceuticals Ltd. 1
- UCB Pharma S.A. 1
- b3c communications 1
- t2cure GmbH 1
122 Current news of European Medicines Agency
FILTERS
Refine your search with the following facets to narrow down your results.
- orphan drugs 8
- stroke 8
- vaccines 8
- cancer 7
- myocardial infarction 7
- pharmacovigilance 7
- Novartis 6
- hypertension 6
- gene therapy 5
- high blood pressure 5
- medicine 5
- cardiovascular diseases 4
- inhibitors 4
- rare diseases 4
- reductions 4
- Genzyme 3
- Marketing Authorization Application 3
- SYGNIS Pharma 3
- UCB 3
- amyotrophic lateral sclerosis 3
- antibodies 3
- bone marrow 3
- breast cancer 3
- chemotherapy 3
- diseases 3
- inflammation 3
- lung diseases 3
- melanoma 3
- milestone payments 3
- multiple sclerosis 3
- pain 3
- pancreatic cancer 3
- tumors 3
- venous thromboembolism 3
- Biofrontera 2
- Brexit 2
- Carrier 2
- Covid-19 2
- Duchenne muscular dystrophy 2
- Friedreich's ataxia 2
- GSK 2
- Genmab 2
- GlaxoSmithKline 2
- Iceland 2
- Life Sciences 2
- Merck Serono 2
- Norway 2
- Pfizer 2
- Sanofi-aventis 2
- Santhera Pharmaceuticals 2
- Spain 2
- T cells 2
- ThromboGenics 2
- Translarna 2
- actinic keratosis 2
- angina 2
- antibiotics 2
- avelumab 2
- blood cancer 2
- cell therapies 2
- cholesterol 2
- coronaviruses 2
- diabetes 2
- drug development 2
- erythropoietic protoporphyria 2
- heart failures 2
- hemophilia A 2
- hepatitis C 2
- hereditary angioedema 2
- immune cells 2
- infectious diseases 2
- interferon 2
- levonorgestrel 2
- liver 2
- merkel cell carcinoma 2
- multiple myeloma 2
- non-Hodgkin lymphoma 2
- osteoarthritis 2
- pandemic influenza 2
- plasticity 2
- prostate cancer 2
- protease inhibitors 2
- regeneration 2
- solution 2
- spinal cord injuries 2
- tissue engineering 2
- vaccine development 2
- validation 2
- veterinary medicine 2
- AA amyloidosis 1
- AGES 1
- AIDS 1
- Abbott 1
- Actelion 1
- Alzheimer's disease 1
- European Medicines Agency (EMA) 122
- Merck KGaA 7
- Novartis International AG 5
- Andrew Lloyd & Associates 3
- Biofrontera AG 3
- Citigate Dewe Rogerson 3
- EuropaBio 3
- Expedeon AG 3
- Genzyme Corporation 3
- GlaxoSmithKline plc (GSK) 3
- Janssen-Cilag N.V. 3
- Pfizer Inc. 3
- U. S. Food and Drug Administration (FDA) 3
- Amsterdam Molecular Therapeutics (AMT) B.V. 2
- Genmab A/S 2
- Kiadis Pharma BV 2
- Merck Serono International S.A. 2
- Oxurion nv 2
- Provepharm SAS 2
- Santhera Pharmaceuticals AG 2
- UCB S.A. 2
- sanofi-aventis Groupe 2
- Æterna Zentaris Inc. 2
- Actelion Pharmaceuticals Ltd 1
- Active Biotech AB 1
- AiCuris GmbH & Co. KG 1
- Ark Therapeutics Group plc 1
- Basilea Pharmaceutica AG 1
- BioMarin Pharmaceutical Inc. 1
- Biogen Inc. 1
- Bionovo, Inc. 1
- CV Therapeutics, Inc. (CVT) 1
- Clavis Pharma ASA 1
- Clinuvel Pharmaceuticals Limited 1
- CureVac AG 1
- Cyclacel Pharmaceuticals, Inc 1
- EUnetHTA 1
- Eisai Co., Ltd 1
- Eisai Europe Ltd. 1
- European Centre for Disease Prevention and Control (ECDC) 1
- European Food Safety Authority (EFSA) 1
- F. Hoffmann-La Roche AG 1
- FORMAC Pharmaceuticals N.V. 1
- FlandersBio 1
- GPC Biotech AG 1
- GVK Biosciences Private Limited 1
- Gendux Molecular Limited 1
- Genentech, Inc. 1
- Genta Inc. 1
- Hybrigenics 1
- Intercell AG 1
- Invitrogen Corporation 1
- Jerini AG 1
- Johnson & Johnson 1
- Keryx Biopharmaceuticals, Inc. 1
- MediGene AG 1
- Merck Sharp & Dohme Limited 1
- Neurochem Inc. 1
- NicOx S.A. 1
- Packer Forbes 1
- Pharming Group N.V. 1
- Stage cell therapeutics GmbH 1
- Swedish Orphan Biovitrum 1
- Takeda Pharmaceutical Company Limited 1
- TiGenix NV 1
- Tibotec Pharmaceuticals Ltd. 1
- UCB Pharma S.A. 1
- b3c communications 1
- t2cure GmbH 1